{"id":23929,"date":"2018-10-04T15:23:04","date_gmt":"2018-10-04T19:23:04","guid":{"rendered":"https:\/\/ipo.org\/?p=23929"},"modified":"2018-10-24T15:24:17","modified_gmt":"2018-10-24T19:24:17","slug":"biosimilars-in-the-antitrust-spotlight-patent-litigation-and-settlement","status":"publish","type":"post","link":"https:\/\/ipo.org\/index.php\/biosimilars-in-the-antitrust-spotlight-patent-litigation-and-settlement\/","title":{"rendered":"Biosimilars in the Antitrust Spotlight: Patent, Litigation and Settlement"},"content":{"rendered":"<p>It\u2019s been a little over five years since the U.S. Supreme Court issued its landmark decision in <em>FTC v. Actavis<\/em>, finding that payments made by brand\u00adname drug companies to generic manufacturers in patent settlements can raise antitrust concerns. The prolific and ongoing litigation stemming from that decision is limited to the small-molecule drugs governed by the Hatch-Waxman regulatory scheme. Now some commentators believe that the FDA has set down a pro-competition gauntlet regarding large molecule biologic drugs governed by the BPCIA \u2014 and that the FTC is not far behind.<\/p>\n<p>Up until now the economic arguments associated with pharmaceutical IP and antitrust litigation were based on the pattern of small molecule drugs, where generics usually achieve a substantial share of the market quickly with large price discounts. But the complexity and costs of developing biosimilar drugs, along with substantially different regulatory and market conditions, has already shaped a different pattern for biosimilar competition, raising new issues of which practitioners need to be aware.<\/p>\n<p>Our panel \u2013 a veteran pharma litigator, an antitrust lawyer who formerly worked at the FTC and who was involved in <em>FTC v. Actavis<\/em>, and a healthcare economist and expert witness \u2013 will address these issues and look ahead and discuss:<\/p>\n<p>-The likely shape of settlements in patent litigation between innovator biologic companies and biosimilar aspirants<br \/>\n-In light of FTC challenges to a series of contemporaneous business deals including patent settlements, the future of non-cash forms of compensation<br \/>\n-As multiple patents in biosimilar infringement litigation can be asserted in staggered waves over time, whether \u201cat-risk\u201d entry is more or less likely than for traditional generic drugs<\/p>\n<p><b>\u00a0<\/b><\/p>\n<p><b>Speakers:<\/b><\/p>\n<ul>\n<li>Nicholas Mitrokostas, <i>Goodwin Procter, LLP<\/i><\/li>\n<li>Richard Mortimer, <i>Analysis Group<\/i><\/li>\n<li>Michael Perry, <i>Baker Botts LLP<\/i><\/li>\n<\/ul>\n","protected":false},"excerpt":{"rendered":"<p>It\u2019s been a little over five years since the U.S.  [&#8230;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-23929","post","type-post","status-publish","format-standard","hentry","category-uncategorized"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Biosimilars in the Antitrust Spotlight: Patent, Litigation and Settlement - Intellectual Property Owners Association<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ipo.org\/index.php\/biosimilars-in-the-antitrust-spotlight-patent-litigation-and-settlement\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Biosimilars in the Antitrust Spotlight: Patent, Litigation and Settlement - Intellectual Property Owners Association\" \/>\n<meta property=\"og:description\" content=\"It\u2019s been a little over five years since the U.S. [...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ipo.org\/index.php\/biosimilars-in-the-antitrust-spotlight-patent-litigation-and-settlement\/\" \/>\n<meta property=\"og:site_name\" content=\"Intellectual Property Owners Association\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/IPOAssociation\/\" \/>\n<meta property=\"article:published_time\" content=\"2018-10-04T19:23:04+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2018-10-24T19:24:17+00:00\" \/>\n<meta name=\"author\" content=\"ipoadmin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@ipo\" \/>\n<meta name=\"twitter:site\" content=\"@ipo\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"ipoadmin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/ipo.org\\\/index.php\\\/biosimilars-in-the-antitrust-spotlight-patent-litigation-and-settlement\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ipo.org\\\/index.php\\\/biosimilars-in-the-antitrust-spotlight-patent-litigation-and-settlement\\\/\"},\"author\":{\"name\":\"ipoadmin\",\"@id\":\"https:\\\/\\\/ipo.org\\\/#\\\/schema\\\/person\\\/8226b50acbf234bbf0f5d70f4a84ba47\"},\"headline\":\"Biosimilars in the Antitrust Spotlight: Patent, Litigation and Settlement\",\"datePublished\":\"2018-10-04T19:23:04+00:00\",\"dateModified\":\"2018-10-24T19:24:17+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/ipo.org\\\/index.php\\\/biosimilars-in-the-antitrust-spotlight-patent-litigation-and-settlement\\\/\"},\"wordCount\":293,\"publisher\":{\"@id\":\"https:\\\/\\\/ipo.org\\\/#organization\"},\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/ipo.org\\\/index.php\\\/biosimilars-in-the-antitrust-spotlight-patent-litigation-and-settlement\\\/\",\"url\":\"https:\\\/\\\/ipo.org\\\/index.php\\\/biosimilars-in-the-antitrust-spotlight-patent-litigation-and-settlement\\\/\",\"name\":\"Biosimilars in the Antitrust Spotlight: Patent, Litigation and Settlement - Intellectual Property Owners Association\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ipo.org\\\/#website\"},\"datePublished\":\"2018-10-04T19:23:04+00:00\",\"dateModified\":\"2018-10-24T19:24:17+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/ipo.org\\\/index.php\\\/biosimilars-in-the-antitrust-spotlight-patent-litigation-and-settlement\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/ipo.org\\\/index.php\\\/biosimilars-in-the-antitrust-spotlight-patent-litigation-and-settlement\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/ipo.org\\\/index.php\\\/biosimilars-in-the-antitrust-spotlight-patent-litigation-and-settlement\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/ipo.org\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Biosimilars in the Antitrust Spotlight: Patent, Litigation and Settlement\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/ipo.org\\\/#website\",\"url\":\"https:\\\/\\\/ipo.org\\\/\",\"name\":\"Intellectual Property Owners Association\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/ipo.org\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/ipo.org\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/ipo.org\\\/#organization\",\"name\":\"Intellectual Property Owners Association\",\"url\":\"https:\\\/\\\/ipo.org\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/ipo.org\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/ipo.org\\\/wp-content\\\/uploads\\\/2019\\\/06\\\/ipo_logo.png\",\"contentUrl\":\"https:\\\/\\\/ipo.org\\\/wp-content\\\/uploads\\\/2019\\\/06\\\/ipo_logo.png\",\"width\":570,\"height\":226,\"caption\":\"Intellectual Property Owners Association\"},\"image\":{\"@id\":\"https:\\\/\\\/ipo.org\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/IPOAssociation\\\/\",\"https:\\\/\\\/x.com\\\/ipo\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/ipoassociation\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/ipo.org\\\/#\\\/schema\\\/person\\\/8226b50acbf234bbf0f5d70f4a84ba47\",\"name\":\"ipoadmin\",\"url\":\"https:\\\/\\\/ipo.org\\\/index.php\\\/author\\\/ipoadmin\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Biosimilars in the Antitrust Spotlight: Patent, Litigation and Settlement - Intellectual Property Owners Association","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ipo.org\/index.php\/biosimilars-in-the-antitrust-spotlight-patent-litigation-and-settlement\/","og_locale":"en_US","og_type":"article","og_title":"Biosimilars in the Antitrust Spotlight: Patent, Litigation and Settlement - Intellectual Property Owners Association","og_description":"It\u2019s been a little over five years since the U.S. [...]","og_url":"https:\/\/ipo.org\/index.php\/biosimilars-in-the-antitrust-spotlight-patent-litigation-and-settlement\/","og_site_name":"Intellectual Property Owners Association","article_publisher":"https:\/\/www.facebook.com\/IPOAssociation\/","article_published_time":"2018-10-04T19:23:04+00:00","article_modified_time":"2018-10-24T19:24:17+00:00","author":"ipoadmin","twitter_card":"summary_large_image","twitter_creator":"@ipo","twitter_site":"@ipo","twitter_misc":{"Written by":"ipoadmin","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ipo.org\/index.php\/biosimilars-in-the-antitrust-spotlight-patent-litigation-and-settlement\/#article","isPartOf":{"@id":"https:\/\/ipo.org\/index.php\/biosimilars-in-the-antitrust-spotlight-patent-litigation-and-settlement\/"},"author":{"name":"ipoadmin","@id":"https:\/\/ipo.org\/#\/schema\/person\/8226b50acbf234bbf0f5d70f4a84ba47"},"headline":"Biosimilars in the Antitrust Spotlight: Patent, Litigation and Settlement","datePublished":"2018-10-04T19:23:04+00:00","dateModified":"2018-10-24T19:24:17+00:00","mainEntityOfPage":{"@id":"https:\/\/ipo.org\/index.php\/biosimilars-in-the-antitrust-spotlight-patent-litigation-and-settlement\/"},"wordCount":293,"publisher":{"@id":"https:\/\/ipo.org\/#organization"},"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/ipo.org\/index.php\/biosimilars-in-the-antitrust-spotlight-patent-litigation-and-settlement\/","url":"https:\/\/ipo.org\/index.php\/biosimilars-in-the-antitrust-spotlight-patent-litigation-and-settlement\/","name":"Biosimilars in the Antitrust Spotlight: Patent, Litigation and Settlement - Intellectual Property Owners Association","isPartOf":{"@id":"https:\/\/ipo.org\/#website"},"datePublished":"2018-10-04T19:23:04+00:00","dateModified":"2018-10-24T19:24:17+00:00","breadcrumb":{"@id":"https:\/\/ipo.org\/index.php\/biosimilars-in-the-antitrust-spotlight-patent-litigation-and-settlement\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ipo.org\/index.php\/biosimilars-in-the-antitrust-spotlight-patent-litigation-and-settlement\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/ipo.org\/index.php\/biosimilars-in-the-antitrust-spotlight-patent-litigation-and-settlement\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ipo.org\/"},{"@type":"ListItem","position":2,"name":"Biosimilars in the Antitrust Spotlight: Patent, Litigation and Settlement"}]},{"@type":"WebSite","@id":"https:\/\/ipo.org\/#website","url":"https:\/\/ipo.org\/","name":"Intellectual Property Owners Association","description":"","publisher":{"@id":"https:\/\/ipo.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ipo.org\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/ipo.org\/#organization","name":"Intellectual Property Owners Association","url":"https:\/\/ipo.org\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/ipo.org\/#\/schema\/logo\/image\/","url":"https:\/\/ipo.org\/wp-content\/uploads\/2019\/06\/ipo_logo.png","contentUrl":"https:\/\/ipo.org\/wp-content\/uploads\/2019\/06\/ipo_logo.png","width":570,"height":226,"caption":"Intellectual Property Owners Association"},"image":{"@id":"https:\/\/ipo.org\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/IPOAssociation\/","https:\/\/x.com\/ipo","https:\/\/www.linkedin.com\/company\/ipoassociation\/"]},{"@type":"Person","@id":"https:\/\/ipo.org\/#\/schema\/person\/8226b50acbf234bbf0f5d70f4a84ba47","name":"ipoadmin","url":"https:\/\/ipo.org\/index.php\/author\/ipoadmin\/"}]}},"_links":{"self":[{"href":"https:\/\/ipo.org\/index.php\/wp-json\/wp\/v2\/posts\/23929","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ipo.org\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ipo.org\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ipo.org\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/ipo.org\/index.php\/wp-json\/wp\/v2\/comments?post=23929"}],"version-history":[{"count":1,"href":"https:\/\/ipo.org\/index.php\/wp-json\/wp\/v2\/posts\/23929\/revisions"}],"predecessor-version":[{"id":23930,"href":"https:\/\/ipo.org\/index.php\/wp-json\/wp\/v2\/posts\/23929\/revisions\/23930"}],"wp:attachment":[{"href":"https:\/\/ipo.org\/index.php\/wp-json\/wp\/v2\/media?parent=23929"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ipo.org\/index.php\/wp-json\/wp\/v2\/categories?post=23929"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ipo.org\/index.php\/wp-json\/wp\/v2\/tags?post=23929"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}